Search

Search Results
Results 7431 - 7440 of 8528 for allergy
  • Drug - 11 Mar 2024
    Consumer Medicine Information (CMI) about DBL Carboplatin Injection (carboplatin) intended for persons living in Australia.
  • Drug - 6 Mar 2024
    Consumer Medicine Information (CMI) about Levetiracetam Viatris (levetiracetam) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Adcetris (brentuximab vedotin) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Esbriet tablets (Pirfenidone) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Esbriet Capsules (Pirfenidone) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Zavedos (Idarubicin hydrochloride) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about DBL Oxaliplatin (oxaliplatin) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about DBL Gentamicin Sulfate (gentamicin) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Gentamicin Injection (gentamicin) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Duavive (Conjugated estrogens/bazedoxifene) intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.